SENP1 and neoplasm: Momordin Ic (MC), an SENP1 inhibitor, enhances SUMO2-pH3(Ser10) cytoplasmic accumulation in normoxic normal, high-glucose and hyper-osmotic conditions, thereby causing M-phase arrest and death of tumour cells.